Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
RESEARCH TOOLSreports
Ultragenyx Pharmaceutical (RARE) Ownership - Who Owns Ultragenyx Pharmaceutical?
580 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 12, 2024 | Thomas Richard Kassberg Cbo & Evp | Sold | $574644 |
| Mar 11, 2024 | Matthew K. Fust Director | Sold | $620443 |
| Mar 05, 2024 | Thomas Richard Kassberg Cbo & Evp | Sold | $69062 |
| Mar 05, 2024 | Theodore Alan Huizenga Svp & Cao | Sold | $24829 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $357597 | |
| Dec 31, 2023 | Sold | $508565 | |
| Dec 31, 2023 | Bought | $662785 | |
| Dec 31, 2023 | Bought | $841632 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,228,570 | Institution | 8.78% | 337,501,933 | |
| 6,875,352 | Institution | 8.35% | 321,010,185 | |
| 4,118,008 | Institution | 5.00% | 192,269,794 | |
| 2,827,898 | Insider | 3.43% | 132,034,558 | |
| 2,230,473 | Institution | 2.71% | 104,140,784 | |
| 2,124,721 | Institution | 2.58% | 99,203,223 | |
| 1,981,385 | Institution | 2.41% | 92,510,866 | |
| 1,522,283 | Institution | 1.85% | 71,075,393 | |
| 1,466,547 | Institution | 1.78% | 68,473,079 | |
| 1,298,543 | Institution | 1.58% | 60,628,973 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,875,352 | Institution | 8.35% | 321,010,185 | |
| 2,230,473 | Institution | 2.71% | 104,140,784 | |
| 2,124,721 | Institution | 2.58% | 99,203,223 | |
| 1,298,543 | Institution | 1.58% | 60,628,973 | |
| 1,280,535 | Institution | 1.56% | 59,788,179 | |
| 1,245,879 | Institution | 1.51% | 58,170,091 | |
| 1,145,534 | Institution | 1.39% | 53,484,982 | |
| 1,039,430 | Institution | 1.26% | 48,530,987 | |
| 1,005,448 | Institution | 1.22% | 46,944,367 | |
| 824,258 | Institution | 1.00% | 38,484,606 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,445,576 | Institution | 2.97% | 126,485,191 | |
| 2,010,557 | Institution | 2.44% | 103,986,008 | |
| 1,492,938 | Institution | 1.81% | 69,899,357 | |
| 1,230,079 | Institution | 1.49% | 63,619,686 | |
| 1,128,371 | Institution | 1.37% | 58,359,348 | |
| 580,782 | Institution | 0.71% | 27,116,712 | |
| 385,287 | Institution | 0.47% | 18,039,137 | |
| 361,650 | Institution | 0.44% | 16,885,439 | |
| 314,066 | Institution | 0.38% | 14,663,742 | |
| 252,201 | Institution | 0.31% | 13,043,836 |
FAQ
Who Owns Ultragenyx Pharmaceutical (RARE)?
Currently, no data Available
What percentage of Ultragenyx Pharmaceutical (RARE) stock is held by institutional investors?
Currently, no data Available
What percentage of Ultragenyx Pharmaceutical (RARE) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Ultragenyx Pharmaceutical (RARE)?
Vanguard owns the most shares of Ultragenyx Pharmaceutical (RARE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.